Why methylene blue is the only option for blocking the cGMP/NO pathway in the treatment of vasoplegic shock? [Editorial]: "reasons that reason itself does not know…" (2021)
- Authors:
- Autor USP: EVORA, PAULO ROBERTO BARBOSA - FMRP
- Unidade: FMRP
- DOI: 10.21470/1678-9741-2021-0957
- Subjects: CIRCULAÇÃO EXTRACORPÓREA; AZUL DE METILENO; CHOQUE; FARMACOTERAPIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Brazilian Journal of Cardiovascular Surgery
- ISSN: 1678-9741
- Volume/Número/Paginação/Ano: v. 36, n. 3, p. I-II, 2021
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
EVORA, Paulo Roberto Barbosa e GOMES, Walter J. Why methylene blue is the only option for blocking the cGMP/NO pathway in the treatment of vasoplegic shock? [Editorial]: "reasons that reason itself does not know…". Brazilian Journal of Cardiovascular Surgery. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.21470/1678-9741-2021-0957. Acesso em: 29 dez. 2025. , 2021 -
APA
Evora, P. R. B., & Gomes, W. J. (2021). Why methylene blue is the only option for blocking the cGMP/NO pathway in the treatment of vasoplegic shock? [Editorial]: "reasons that reason itself does not know…". Brazilian Journal of Cardiovascular Surgery. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.21470/1678-9741-2021-0957 -
NLM
Evora PRB, Gomes WJ. Why methylene blue is the only option for blocking the cGMP/NO pathway in the treatment of vasoplegic shock? [Editorial]: "reasons that reason itself does not know…" [Internet]. Brazilian Journal of Cardiovascular Surgery. 2021 ; 36( 3): I-II.[citado 2025 dez. 29 ] Available from: https://doi.org/10.21470/1678-9741-2021-0957 -
Vancouver
Evora PRB, Gomes WJ. Why methylene blue is the only option for blocking the cGMP/NO pathway in the treatment of vasoplegic shock? [Editorial]: "reasons that reason itself does not know…" [Internet]. Brazilian Journal of Cardiovascular Surgery. 2021 ; 36( 3): I-II.[citado 2025 dez. 29 ] Available from: https://doi.org/10.21470/1678-9741-2021-0957 - Endothelium dysfunction classification: why is it still an open discussion?.[Carta]
- Asymmetric dimethylarginine endogenous inhibition of nitric oxide synthase causes differential vasculature effects
- Letter by Gomes and Evora regarding article, "Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome" [Carta]
- Mitral stenosis acute pulmonary edema and rheumatic fever pneumonitis: a hypothesis to an old enigma [carta]
- High conductance potassium channels activation by acid exposure in rat aorta is endothelium-dependent
- Biological aortic heart valve prosthesis in patients under 65 years old. [Carta]: are the paradigms changing ?
- Cardiopulmonary bypass in myocardial revascularization surgery in the State of São Paulo [Editorial]: the REPLICCAR study
- G-proteins agonists and NO/cGMP blockers [Editorial]: unexplored frontiers in the pharmaceutical industry
- Thirtieth anniversary of the Brazilian Journal of Cardiovascular Surgery. And devising the next decades. [Editorial]
- Is the cardiopulmonary bypass systemic inflammatory response overestimated ?. [Editorial]
Informações sobre o DOI: 10.21470/1678-9741-2021-0957 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003072751.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
